Cyclin-dependent kinase (Cdk) Cdk1-Cyclin A can phosphorylate Flap endonuclease 1 (Fen1), a key-enzyme of the DNA replication machinery, in late S phase. Cdk1-cyclin A forms a complex in vitro and in vivo with Fen1. Furthermore, Fen1 phosphorylation is detected in vivo and depends upon Cdks activity. As a functional consequence of phosphorylation by Cdk1-Cyclin A in vitro, endo-and exonuclease activities of Fen1 are reduced whereas its DNA binding is not affected. Moreover, phosphorylation of Fen1 by Cdk1-Cyclin A abrogates its proliferating cell nuclear antigen (PCNA) binding thus preventing stimulation of Fen1 by PCNA. Concomitantly, human cells expressing the S187A mutant defective for Cdk1-Cyclin A phosphorylation accumulate in S phase consistent with a failure in cell cycle regulation through DNA replication. Our results suggest a novel regulatory role of Cdks onto the end of S phase by targeting directly a key enzyme involved in DNA replication.
Introduction
Cyclin-dependent kinases (Cdks) are essential activators of replication initiation and are also required for onceper-cell cycle control of DNA replication (Vas et al., 2001) . Eukaryotic DNA replication initiates at many replication origins so that several replication forks can work simultaneously. This allows replication of large genomes in a short S phase (Stillman, 1996; Donaldson and Blow, 1999) . Entry into S phase and cell-cycle progression are tightly regulated by active kinase complexes composed by a positive regulatory subunit called Cyclin and a catalytic subunit, the Cdk subunit (Fotedar and Fotedar, 1995) . The pairs of Cdk-Cyclin found in these complexes are Cdk4/6-Cyclin D, Cdk2-Cyclin E, Cdk2/1-Cyclin A and Cdk1-Cyclin B (Morgan, 1996) . The G0-G1 transition is regulated by Cdk4/6-Cyclin D and G1-S transition by Cdk2-Cyclin E. Cdk2-Cyclin A and Cdk1-Cyclin A are activated during S phase. Cdk2-Cyclin A activity rises throughout S phase whereas Cdk1-Cyclin A activity appears later in correlation with the end of DNA synthesis. Finally, the G2-M transition is regulated by Cdk1-Cyclin B (Nigg, 1995; Nurse, 2000) . The different Cdk-Cyclin complexes display distinct physiological functions. Cdk4-Cyclin D can phosphorylate the retinoblastoma gene product pRb, which sequesters transcription factors, to allow the progression into S phase (Hinds and Weinberg, 1994) . In mitosis, the nuclear lamina is disassembled by a direct Cdk1-Cyclin B phosphorylation (Nigg, 1995) . DNA replication proteins such as large SV40 T antigen (McVey et al., 1993) , DNA polymerase a/primase (Voitenleitner et al., 1997; Schub et al., 2001) , DNA polymerase d (Wu et al., 1998; Ducoux et al., 2001) , replication protein A (Dutta and Stillman, 1992) and DNA ligase I (Rossi et al., 1999) are all substrates for Cdk-Cyclin (reviewed in Henneke et al., 2003) . In addition to Cdks, other protein-modifying factors such as protein phosphatase 2A (PP2A) and Cdc7-Dbf4 kinase (DDK) have essential functions in triggering S phase and initiating DNA replication (Lin et al., 1998; Johnston et al., 1999 Johnston et al., , 2000 . Since we recently showed that acetylation regulates flap endonuclease 1 (Fen1) activity through the transcriptional coactivator p300 (Hasan et al., 2001) , we addressed the question whether Fen1 could be involved in other post-translational modifications. We found three potential sites of phosphorylation by Cdks (Ser-16, Ser-157 and Ser-187) and we tested if phosphorylation might be a novel regulatory mechanism for Fen1. 5 0 exonuclease-1 or Fen1 is a structure-specific metallonuclease that plays an important role in multiple DNA metabolic processes (Lieber, 1997) . In DNA replication, it is required for Okazaki fragment maturation where it participates in the removal of the displaced RNA-DNA primers (Bambara et al., 1997) . In DNA repair, Fen1 is required for long-patch base excision repair (BER) (Klungland and Lindahl, 1997; Kim et al., 1998) . Genetic analyses of the Fen1 homologue RAD27 in Saccharomyces cerevisiae have shown that the gene is not essential for viability (Sommers et al., 1995) . However, yeast Fen1-null mutant yeast strains revealed a pleiotropic phenotype including temperature-sensitivity for growth, sensitivity to methyl methane sulphonate (MMS) and UV radiation (Reagan et al., 1995) . Elevated rates of mitotic recombination because of the presence of destabilized repetitive sequences (Gordenin et al., 1997; Henricksen et al., 2000) . Moreover, Fen1 has been proposed to be involved in telomere stability (Parenteau and Wellinger, 1999) and nonhomologous end-joining (NHEJ) (Wu et al., 1999) . Recently, Fen1 haploinsufficiency has been demonstrated to lead to rapid tumour progression in mice (Kucherlapati et al., 2002) . As chicken cells lacking Fen1 were viable but hypersensitive to methylating agents and H 2 O 2 , it was suggested that Fen1 functions in BER in vertebrate cells (Matsuzaki et al., 2002) . In summary, Fen1 is a multifunctional enzyme in vivo for maintaining genome stability.
As the role of Fen1 in DNA replication and repair is becoming more clear, several groups are interested to structurally characterize this enzyme, and the crystal structures of two archaeal orthologous Fen1 have so far been solved (Hosfield et al., 1998; Hwang et al., 1998) . For DNA repair and replication, Fen1's structural recognition of the 5 0 flap is essential. Moreover, we recently have described that the flexible loop of human Fen1 is required for flap cleavage activity (Storici et al., 2002) . The current model predicts that Fen1 tracks down the 5 0 flap until it reaches duplex DNA (Murante et al., 1995) and releases the unannealed single-stranded region at the junction region by endonucleolytic cleavage (Harrington and Lieber, 1994a, b) . Fen1 does not cleave bubble substrates, single-stranded 3 0 flaps, heterologous loop, or holiday junctions whereas DNA substrates containing nicks or small gaps can be processed by the 5 0 -3 0 exonuclease activity. Although Fen1 acts most efficiently as a flap endonuclease, it is likely that similar enzymatic mechanisms are involved for its exonuclease activity (Lieber, 1997) . Fen1 interacts with several proteins at the replication fork, such as PCNA (Li et al., 1995; Wu et al., 1996; Jo´nsson et al., 1998) , Dna2 helicase/endonuclease (Budd and Campbell, 1997) , Werner syndrome helicase/exonuclease (WRN) (Brosh Jr et al., 2001) and replication protein A (Biswas et al., 1997) . The Dna2 helicase/endonuclease can physically and genetically interact with RAD27 in budding yeast (Budd and Campbell, 1997) , and both play a direct role in Okazaki fragment maturation Kang et al., 2000) . Moreover, since WRN protein and Fen1 physically interact, an alternative pathway during DNA replication and/or repair has been proposed (Brosh Jr et al., 2001) . The interaction of PCNA with Fen1 results in a stimulation of its endonuclease activity in vitro under physiological ionic conditions .
In this study, we report that exo-and endonuclease activities of Fen1 are inhibited in vitro upon phosphorylation by the Cdk1-Cyclin A complex. Phosphorylation of Fen1 abolishes its PCNA binding thus preventing stimulation of Fen1 by PCNA. Fen1 is phosphorylated in vivo and phosphorylation is reduced by a specific Cdks inhibitor. Fen1 can form a complex in vitro and in vivo with Cyclin A-dependent kinases. Moreover, human cells expressing the Fen1 S187A mutant defective for phosphorylation by Cdk1-Cyclin A accumulate in S phase consistent with a failure in cell cycle regulation through DNA replication. Together, our results suggest a novel role for Cdks onto the regulation of replication fork functionality through cell cycle phosphorylation of Fen1, a key enzyme in DNA replication.
Results

Fen1 is phosphorylated in vitro by Cdk-Cyclin complexes
Since DNA replication proteins are targets of Cyclindependent kinases, we investigated whether Cdk-Cyclin complexes involved in S phase could phosphorylate Fen1. Purified Cdk1-Cyclin A, Cdk2-Cyclin A and Cdk2-Cyclin E were incubated with 100 and 500 ng Fen1 into an ATP-dependent kinase assay. All three Cdk-Cyclin complexes were able to phosphorylate Fen1 as well as the positive control histone H1 (Figure 1a) . Furthermore, the kinase inhibitor p21
Cipl,WAF-1 prevented phosphorylation at a p21/Fen1 ratio of 1 : 1 suggesting that phosphorylation was specific to Cdk kinases ( Figure 1b) . From these experiments, we concluded that Fen1 is a target for Cdk phosphorylation in vitro.
Fen1 is phosphorylated in vivo and its phosphorylation depends on Cdks activity
To test whether Fen1 is phophorylated in vivo, 293 T cells were transfected with a vector expressing myctagged Fen1. After nuclear extracts preparation, myctagged Fen1 protein was immunoprecipitated using the anti-myc-specific antibody and subsequently analysed by Western blot using the anti-Fen 1 antibody. After stripping, the same membrane was reprobed with a specific antiphosphorylated serine antibody. Western blots analysis clearly showed a band migrating at the same position of myc-tagged Fen1 (Figure 2a) . No signal was observed in the negative control. To see whether phosphorylation of Fen1 was linked to Cdks activity, myc-tagged Fen1 was expressed in 293T cells treated during 24 h with 40 mm Olomoucine (a specific inhibitor of Cdk1 and Cdk2) (Abraham et al., 1995) dissolved in DMSO. Cells treated with DMSO alone were used as a negative control. Myc-tagged Fen1 was then immunoprecipitated from nuclear extract using the anti-myc antibody. Immunoprecipitations including the DMSO control and Olomoucine treatment were loaded three times. Two Western blots were performed, one against Fen1 and another against proteins phosphorylated on serine. The other part of the samples was used for a silver staining (Figure 2b ). The immunoblot using Fen1 antibody showed that Fen1 was specifically isolated from each extract DMSO and Olomoucinetreated cells. When the antiphosphorylated serine antibody was used, the signal at the position of myc-tagged Fen1 was more than 10 times reduced after Olomoucine treatment compared to DMSO (see middle blot in Figure 2b ). This result was not because of a difference in the amount of myc-Fen1 immunoprecipitated as observed from the silver-stained gel. Taken together these results indicated that Fen1 is phosphorylated in vivo by Cdks and that phosphorylation is 10 times reduced upon treatment with the Cdks-specific inhibitor Olomoucine.
Fen1 phosphorylation increases throughout S phase
Entry into S phase and cell cycle progression are tightly regulated by Cdks. The G1-S transition is regulated by Cdk2-Cyclin E. Cdk2-Cyclin A and Cdk1-Cyclin A are activated during S phase. Cdk1-Cyclin A activity rises throughout S phase whereas Cdk1-Cyclin A activity appears later in correlation with the end of DNA synthesis (Nigg, 1995; Nurse, 2000) . Consequently, we investigated Fen1 phosphorylation during the cell cycle and more precisely during S phase. 293T cells expressing transiently a myc-tagged Fen1 were blocked at the G1/ S phase transition upon treatment by hydroxyurea (4 mm). The cells were then released for 3 h to reach S phase, as observed from the flow cytometry analysis (Figure 3a) . In parallel, cells were released for 6 h and were then distributed in late S and G2 phases. Myctagged Fen1 immunoprecipitated from nuclear extract was used for two Western blots, one against Fen1 and another against proteins phosphorylated on serine (Figure 3b ). The immunoblot using Fen1 antibody showed that Fen1 was specifically isolated. Using the antiphosphorylated serine antibody, the signal at the position of myc-tagged Fen1 increased fivefold when the cells were in the late S phase compared to the cells in S phase. Moreover, the assumption that the phosphorylated form of Fen1 in S phase is likely because of Cdk activity (Figure 3b ) is confirmed by the abolishment of its phosphorylation status upon Olomoucine treatment, the specific inhibitor of Cdk1 and Cdk2 (Figure 2b ). Thus, Fen1 phosphorylation is likely cell cycle regulated and increased when the cells progress into S phase.
Fen1 binds Cdk1, Cdk2 and Cyclin A in vitro and in vivo
Given the fact that Fen1 is a DNA replication protein involved in Okazaki fragment processing and a potential target for Cdks phosphorylation, we next tested a direct interaction between Cdk1, Cdk2 and Cyclin A. Moreover, Fen1 contains two putative Cyclin-Cdk binding motifs. Indeed, the core sequence ZRXL, where Z and X are conserved basic residues, is present at position 191 and 260 (Adams et al., 1996) . We established pull-down assays using GST-Cdk1, GST-Cdk2 and GST-Cyclin A fusion proteins. Purified recombinant Fen1 was incubated with the GST fusion proteins immobilized onto glutathione-sepharose beads. Bound Fen1 was detected by immunoblotting using the anti-Fen1 antibody. Figure 4a shows the interaction of Fen1 with Cdk1, Cdk2 and Cyclin A. PCNA was used as a positive control, and the DNA binding region of RF-Cp140 (RF-C A) and GST alone as negative controls. To examine whether endogenous Cyclin A-dependent kinases complexes and Fen1 interact in vivo, coimmuno- unannealed single-stranded region at the junction region by endonucleolytic cleavage (Harrington and Lieber, 1994a, b) . Considering the two-steps Fen1 mechanism, we first analysed whether phosphorylation of Fen1 could influence its DNA binding ability. For this study, a DNA magnetic beads assay was used. In a preliminary experiment, we verified that 1.6 pmol of Cdk1-Cyclin A was sufficient to completely phosphorylate up to 11.5 pmol of Fen1 and this phosphorylation was ATPdependent (data not shown). Therefore, we decided to use these optimized saturating conditions for all the following experiments to study the effect of phosphorylation. Then, phosphorylated ( Having shown that the phosphorylated form of Fen1 can be retained onto a flap template, its functional consequence was next tested. At low-salt concentrations, Fen1 displays nuclease activity in the absence of its accessory protein PCNA (Jo´nsson et al., 1998) . Phosphorylated and unphosphorylated Fen1 were tested in a flap cleavage assay including three annealed oligonucleotides that form a radioactively labelled flap structure as a substrate (Figure 5b ). Fen1 was first preincubated with Cdk1-Cyclin A (either in the presence or absence of ATP) and incubated with the flap substrate. Titrations of unphosphorylated (without ATP) and phosphorylated (with ATP) Fen1 were performed in order to quantify the effect of Fen1 phosphorylation (Figure 5b ). These results indicated that phosphorylation of Fen1 reduces its endonuclease activity. Addition of Cdk1-Cyclin A and ATP alone had no effect on Fen1 cleavage (data not shown) confirming that phosphorylation is directly involved in reducing Fen1 endonuclease activity. Indeed, 2.8 ng of phosphorylated Fen1 hydrolysed 22% of the flap DNA in 15 min instead of 70% with the unphosphorylated enzyme (Figure 5c ). These data indicated a threefold inhibition of endonuclease activity of the phosphorylated Fen1. Since Fen1 is active as a 5 0 -3 0 exonuclease at nicks in duplex DNA with lower efficiency (Lieber, 1997), we also examined whether Immunoprecipitations performed with anti-myc antibody were loaded for two immunoblots: one against Fen1 and one against phosphorylated serine. The negative control (À) was an immunoprecipitation with mouse antibody IgG1. A measure at 10 mg of nuclear extract was loaded Regulation of DNA replication by phosphorylation of hFenl G Henneke et al phosphorylation could affect its exonuclease activity. Phosphorylated and unphosphorylated Fen1 were titrated onto a linear duplex DNA containing a nick (Figure 5e ). Fen1 digests the upstream oligonucleotide exonucleolytically in the 5 0 -3 0 direction, thus releasing a labelled 5 0 mononucleotide, which can be resolved and quantified (as outlined in Materials and methods). The data showed that phosphorylation of Fen1 corresponds to a threefold inhibition of the Fen1 exonuclease activity (Figure 5f ) and this effect was not because of the presence of Cdk1-Cyclin A and ATP (data not shown). In summary, our results demonstrated that phosphorylation of Fen1 by Cdk1-Cyclin A reduces its exo-and endonuclease activities about threefold.
Phosphorylation of Fen1 by Cdk1-Cyclin A prevents its PCNA binding and consequently abolishing PCNA stimulation Fen1 interacts with several proteins at the replication fork including PCNA (Jo´nsson et al., 1998) and it binds to PCNA (Li et al., 1995) via the PCNA interaction domain called PIP-box motif (Warbrick et al., 1997) . To test whether phosphorylation of Fen1 could affect its PCNA binding, we used pull-down assays (Figure 6a ). Purified recombinant Fen1 was phosphorylated in vitro by Cdk1-Cyclin A and subsequently incubated with the GST-PCNA fusion protein immobilized onto glutathione-sepharose beads. GST was used as a negative control. Bound Fen1 was detected by immunoblot using the anti-Fen1 antibody. As expected, unphosphorylated Fen1 (Figure 6a , lanes 4 and 5) was able to bind PCNA, but on the other hand phosphorylated Fen1 could not bind PCNA (Figure 6a, lane 6 ). An identical result was obtained when Fen1 was phosphorylated by Cdk2-Cyclin A (data not shown). Fen1-PCNA interaction was not affected when Cdk1-Cyclin A was incubated alone with Fen1 in the absence of ATP (Figure 6a , lane 4) ruling out the possibility of a binding interference because of the presence of the Cdk1-Cyclin A complex. In addition, Figure 6a clearly showed nearly identical levels of Fen1 in lanes 4 and 5, thus excluding any competition among the proteins. These data suggested that phosphorylation of Fen1 by Cdk1-Cyclin A prevents its PCNA binding.
Kinetic analysis revealed that PCNA enhances Fen1 binding stability, thus increasing the cleavage efficiency Tom et al., 2000) . To efficiently stimulate Fen1 activity, the PCNA trimer must encircle the DNA and must be 'below' the flap (Jo´nsson et al., 1998) . It has been shown that PCNA can stimulate Fen1 activity under physiological salt concentrations but not under low-salt concentrations (Li et al., 1995) . When PCNA-dependent Fen1 activity was determined at 125 mm NaCl, Fen1 alone was virtually inactive as expected (Jo´nsson et al., 1998) . Fen1 was preincubated with Cdk1-Cyclin A (either in the presence or absence of ATP) and then incubated with the linear flap DNA substrate. A limiting amount of Fen1 was used (6.72 fmol) such that the flap cleavage was not detectable in the absence of PCNA (Figure 6b and c, lane 1) . Addition of PCNA that can be loaded spontaneously onto the flap substrate stimulated as expected, the nuclease activity of unphosphorylated Fen1 (Figure 6b and c, lanes 2-4). Incubation of Cdk1-Cyclin A and ATP alone had no effect on the Fen1 flap cleavage ruling out an interference because of the presence of the Cdk1-Cyclin A complex. In addition, our previous studies failed to identify PCNA being phosphorylated by Cyclin/Cdks (Koundrioukoff et al., 2000) , thus excluding the contribution of PCNA to the changes in Fen1-PCNA affinity. Interestingly, PCNA stimulation with phosphorylated form of Fen1 could not be detected even in the presence of a large stoichiometric excess of PCNA (2000 fmol) (Figure 6d ). These data clearly demonstrated that upon phosphorylation by Cdk1-Cyclin A, Fen1 cannot be stimulated by PCNA any more, which is consistent with its inability to bind PCNA.
Fen1 S187A mutant defective in Cdk1-Cyclin A phosphorylation is enzymatically active and colocalizes with PCNA in the S phase Three potential Cdks consensus phosphorylation sites were identified in human Fen1 (S16, S157 and S187). Next, we performed site-directed mutagenesis on these three serines that were substituted into alanines. The three mutants were produced in Escherichia coli and The results indicated that S187 is the only target for Cdk1-Cyclin A and confirmed the specificity of Fen1 phosphorylation by Cdk1-Cyclin A. Moreover, the Fen1 S187A mutant was enzymatically active in a flap endonuclease assay (Figure 7b ), and incubation of the Fen1 S187A into a Cdk1-cyclin A-dependent kinase assay did not affect its endonuclease activity (Figure 7c ). This control experiment confirmed that the S187A mutant could not be phosphorylated by Cdk1-Cyclin A, therefore strengthening the inhibition of the wildtype (WT) Fen1 activity by phosphorylation on S187. Besides, the Fen1 S187A mutant colocalized with PCNA during S phase when it is ectopically expressed in HeLa cells (Figure 7d ). Taken together, these results demonstrated that the Fen1 S187A mutant is fully active and shows the same subcellular localization as the WT Fen1.
Expression of the Fen1 S187A mutant into 293 cells delays the S phase
The idea that Fen1 phosphorylation increases at the end of S phase was tested by carrying out a kinetic analysis on synchronized 293 cells and evaluating the amount of Fen1 immunoprecipitated as well as its phosphorylation status. Compared to the Fen1 S187A mutant, immunoprecipitation of WT Fen1 results in the similar level of Fen1 at times 0 and 4 h (Figure 8a , anti-Fen1). The This was likely because of the phosphorylation of WT Fen1 in vivo in correlation with its abolishment of PCNA binding after phosphorylation (see also Figure 6a ). Since phosphorylation by Cdk1-Cyclin A can prevent PCNA-Fen1 interaction and thus inactivating Fen1 nuclease activity at the end of S phase, we also analysed the physiological relevance of the S187A Fen1 mutant by transient expression in 293 cells, taking into account that this mutant was enzymatically fully active in vitro (Figure 7b ). Transfected cells were analysed as outlined in Materials and methods with the WT, the S187A Fen1 mutant and vector alone as negative control (data not shown). The S187A Fen1 mutant caused a two-to threefold accumulation of cells in S phase compared to the WT (Figure 8b ). Interestingly, this finding was observed both for unsynchronized as well as synchronized 293 cells in S phase after a hydroxyurea block followed by a release at 105 and 210 min, suggesting a delay in S phase for the cells expressing the S187A Fen1 mutant.
Discussion
The findings in this paper give evidence that Fen1 is a substrate for Cdks. Fen1 can interact directly with Cyclin A, Cdk1 and Cdk2 in vitro. The interactions were confirmed in vivo while Cyclin-A-dependent kinases form a complex with Fen1 in the HeLa nucleus. Furthermore, Fen1 phosphorylation by Cdk2-Cyclin A and Cdk1-Cyclin A is detected in vitro and depends upon Cdks activity in vivo. The phosphorylation state of Fen1 appears to be cell cycle regulated and increases when the cells progress into S phase. As a functional consequence of phosphorylation, Fen1 exo-and endonuclease activities are reduced in vitro by Cdk1-Cyclin A. The inhibitory effect of Fen1 phosphorylation on its enzymatic activity is likely because of a local conformational change rather than a defect in DNA binding as no difference in ability to bind DNA could be detected. The primary structure of Fen1 shows three potential phosphorylation sites by Cdks (S/T P motif): serines 17, 157 and 187. We identified the serine 187 within Fen1 as the only one residue that could be phosphorylated by Cdk1-cyclin A in vitro. It is located into the internal nuclease domain of Fen1. Despite the lack of structural data about this domain, we propose that phosphorylation of the serine 187 enhances a local conformational change that possibly affects the nuclease activity of Fen1. Fen1 endonuclease activity was also tested under physiological salt conditions, where enzymatic activity is completely PCNA-dependent (Jo´nsson et al., 1998) . The phosphorylated Fen1 could not be stimulated by PCNA and this correlated with the abolishment of its PCNA binding. This result suggested that phosphorylation could also have an effect on the folding of the PCNA-binding region. The current in vitro evidence indicates that the phosphorylation status of Fen1 by Cdk1-Cyclin A might downregulate the replication fork functionality by directing the cells to exit S phase. Along this line, we observed accumulation of cells in S phase upon expression of the serine 187 Fen1 mutant. The level of phosphorylated Fen1 increased at the end of S phase in correlation with the expression of Cyclin A and with a lack of interacting PCNA (Figure 8a ). This result is in agreement with the abolishment of the interaction between the phosphorylated Fen1 and PCNA observed in vitro (Figure 6a ). Under such circumstances, one would expect a dramatic decrease of pulled-down PCNA with the phosphory- (Figure 8a ) is likely because of the fact that the pool of myc-tagged Fen1 overexpressed was not completely phosphorylated.
Our results suggest a novel regulatory role of Cdk by targeting a key enzyme involved in DNA synthesis. Taken together, the data presented lead us to propose the following model: When DNA synthesis of the upstream Okazaki fragment is completed, DNA polymerase d displaces both RNA and DNA of the downstream fragment, generating an unannealed 5 0 -flap. Fen1 nuclease prefers a flap substrate, removing the flap at the point of annealing. Fen1 has been postulated to enter the flap from the 5 0 unannealed 5 0 -end, to track the annealing point, and then to endonucleolytically cleave (Harrington and Lieber, 1994a; Murante et al., 1995; Wu et al., 1996) . The presence of PCNA at cleavage site trapped Fen1 at the junction and stimulates its enzymatic endonuclease activity , thus removing the entire RNA primer. Then, a ligatable nick is created and sealed by the DNA ligase I. Upon phosphorylation by Cdk1-cyclin A occurring at the end of S phase, the remaining Fen1 molecules would then dissociate from the DNA replication site as a result of its inability to interact with PCNA and not to be further endonucleolytically stimulated. Then, free PCNA molecules are available to interact with DNA ligase I for sealing the resulting nick substrate. This model would provide a potential link for the cell cycle control of DNA replication. It Figure 7 The Fen1 S187A mutant defective for Cdk1-Cyclin A phosphorylation is enzymatically active and colocalizes with PCNA in S phase. (a) WT Fen1 and S16A, S157A, S187A mutants have been tested in Cdk1-Cyclin A kinase assays. (b) Activity of the WT Fen1 and the S187A Fen1 mutant were analysed by titration (0.25, 2.5, 25 and 250 ng) into a flap endonuclease assay. (c) Endonuclease activity of the S187A Fen1 was analysed by titration (0.28, 2.8 and 28 ng) after incubation into a Cdk1-Cyclin A-dependent kinase assay (as outlined in Figure 5b Eukaryotic DNA replication is tightly controlled and occurs during a restricted period of the cell cycle, the S phase. S phase entry as well as cell cycle progression in general is enhanced by the activity of the conserved serine/threonine protein kinases, the Cdks. Despite detailed knowledge of general cellular Cdk functions, relatively little is known about their physiological substrates and how Cdks trigger the end of DNA replication. Our data suggest that cell cycle-dependent phosphorylation is a novel regulatory mechanism for Fen1 by directing cells to exit from S phase and demonstrate that Cdks enhance the end of the DNA replication by inactivating a protein involved in DNA replication fork progression. Cell cycle regulation of other DNA replication proteins such as DNA polymerase d (Wu et al., 1998; Ducoux et al., 2001) , replication protein A (Dutta and Stillman, 1992) , DNA polymerase a/primase (Voitenleitner et al., 1997; Schub et al., 2001) and DNA ligase I (Rossi et al., 1999) have been described. The modification of each protein upon phosphorylation by an active kinase in S phase leads to a negative effect on their function. This observation leaves open the possibility that a synergistic downregulation of replication proteins appears to be necessary to terminate DNA replication. Our hypothesis is strongly supported by a very recent finding showing a cell cycle-dependent dynamic association of CyclinCdks complexes with DNA replication proteins (Frouin et al., 2002) . Together, these observations would support the hypothesis that cell cycle phosphorylation of Fen1 participates to the downregulation of DNA replication in mammalian cells.
Although phosphorylation is required to downregulate DNA replication, we can not exclude that additional post-translational modifications (glycosylation, methylation, sumoylation, ubiquitination, acetylation, polyglutamylation) happen into other DNA metabolic events. This may account for an accurate regulation by protein modifications. The relative importance of basic mechanistic strategies involved at different times during cell cycle seems to be a prerequisite for genome maintenance in human cells.
Materials and methods
Nucleic acids
Oligonucleotides for preparing flap and nicked substrates were purchased from Microsynth GmbH (Balgach, Switzerland). Oligomer sequences are listed in Table I (see supplementary  information) . Prior to annealing, oligonucleotides Ft2_01 and Ft2_05 were labelled at the 5 0 end using [g-32 P] ATP and T4 polynucleotide kinase. Free ATP was removed on a MicroSpint G-25 column. To generate the substrates, the appropriate primers were mixed at a 1 : 1 molar ratio in 20 mm TrisHCl (pH 7.4), 150 mm NaCl, heated to 751C, and slowly cooled to room temperature. The nicked and flap substrates contain, respectively, downstream primers Ft02_05 and Ft02_01 and the upstream primer Ft02_02 annealed to the complementary Ft02_04 oligonucleotide. To generate human GST-Cdk1 fusion protein, cDNA encoding WT Cdk1 was PCR-amplified from the plasmid pCDNA3.1/Cdc2-HA (gift from JP Magyar). The resulting fragment was cloned into a pGEX-3X and sequenced to confirm the absence of mutations. The primers used were 5 0 -GGAATTGCCCTTGGATCCATG-GAAGATTATACC-3 0 and 5 0 -CTGGGACGTCCTCGAGT-CACATCTTCTTAATCTG-3 0 . The pET23/C-His-Fen1 was used as a template for mutagenesis to generate Fen1 muations using the following nucleotides: S16A, pGCTGATGTGG-CCCCCGCTGCCATCCGGGAGAATG; S157A, pCTTAT-CTTGATGCACCCGCTGAGGCAGAGGCCAGC; S187A, pCTGCCTCACCTTCGGCGCCCCTGTGCTAATGCG.
Proteins
Human PCNA was produced in E. coli using the plasmid pT7/ hPCNA (gift from A Dutta) and purified to homogeneity as described (Schurtenberger et al., 1998) . Human replication protein A was overexpressed in E. coli strain BL21(DE3) harbouring the expression plasmid p11d-tRP-A and purified according to the methods of Henricksen et al. (1994) . Human Fen1 was produced in E. coli BL21(DE3)pLysS using the plasmid pET23d and purified as described . The purified Cdk-Cyclin complexes were a kind gift from HP Nasheuer.
Fen1 assays
Endonuclease and exonuclease assays were performed in a final volume of 12.5 ml containing 40 mm Tris-HCl (pH 7.5), 10 mm MgCl 2 , 5 mm dithiothreitol (DTT), 200 mg/ml bovine serum albumin (BSA), 50 fmol of DNA substrates. After the addition of phosphorylated or unphosphorylated Fen1, the reactions were incubated at 301C for 15 min and stopped with 2.5 Â stop buffer (95% formamid, 20 mm EDTA, 0.05% (w/v) each bromophenol blue and xylene cyanol). For PCNA stimulation, the assays were performed in 13 ml containing 50 mm Bis-Tris (pH 6.5), 125 mm NaCl, 10 mm MgCl 2 , 1 mm DTT, 0.25 mg/ml BSA, 40 fmol flap substrate and the indicated amounts of PCNA. Reactions were carried out for 30 min at 301C with phosphorylated or unphosphorylated Fen1 and quenched with stop buffer. The products were separated onto 15% denaturating gels, visualized by autoradiography and quantified on a PhosphorImager using the Image-Quant software (Molecular Dynamics).
DNA binding assays
A biotinylated 284 fragment homologous to M13mp18 DNA from 6140 to 6423 bp was PCR amplified with upstream biotinylated primer BP-6140 (30 nt) and dowstream primer BP-6423 (25 nt). Biotinylated 284 nt was immobilized onto streptavidin-magnetic beads (Dynabeads) in buffer A (10 mm Tris-HCl (pH 7.5), 1 mm EDTA, 2 M NaCl), for 2 h 30 min at room temperature. Unbound products were washed off the beads twice with buffer B (10 mm Tris-HCl (pH 7.5), 1 mm EDTA, 1 m NaCl), and the duplex DNA was denaturated with 0.1 m NaOH. Nonbiotinylated nucleotides were removed with buffer B. The beads-bound biotinylated 284 fragment was annealed with D-45 and F-31 or C-30 and F-31 primers (see Table I ) to create the flap and nicked templates, respectively. DNA beads bound templates were washed with buffer B and resuspended in buffer C (30 mm HEPES-NaOH (pH 7.5), 8 mm magnesium acetate, 0.2 mg/ml BSA, 1 mm DTT). Binding assays were carried out in a final volume of 16 ml. 50 fmol volume of DNA templates were coated with 1.5 pmol of RP-A for 2 min on ice and washed with buffer D (30 mm HEPES- NaOH (pH 7.5), 5% (v/v) glycerol, 0.1 mg/ml BSA, 1 mm DTT, 0.01% (v/v) Nonidet P-40, 0.1 mm EDTA). Reaction were performed into buffer C with 0.7 pmol of phosphorylated or unphosphorylated Fen1 for 1 min at 301C. Then, magnetic beads were washed off with buffer D and immediately resuspended in SDS sample buffer. DNA binding proteins were resolved on a 12% SDS-polyacrylamide gels and subsequently transferred to a PVDF membrane. The membrane was probed with rabbit polyclonal anti-hFen1 purified antibody (produced at the animal facility in the Institute of animal breeding of the University of Zu¨rich) followed by horse anti-rabbit IgG-horseradish peroxidase (HRP, Sigma) and Enhanced ChemiLuminescence (ECL, Pierce).
GST pull-down experiments
For in vitro binding, 10 ml of glutathione-sepharose beads were incubated with either 2 mg of purified GST-RF-C A or 100 mL E. coli extract containing overexpressed GST fusion proteins for 3 h at 41C. GST fusion proteins bound on beads were incubated with 100 ng of phosphorylated or unphosphorylated Fen1. After 1 h at 41C, the beads were washed four times with 50 mm Tris (pH 8), 120 mm NaCl, 0.5% (v/v) Nonidet P-40, 1 mm DTT, 1 mm PMSF (binding buffer), and the bound proteins were eluted with 50 mm Tris (pH 6.8), 2 mm EDTA, 1% (w/v) b-mercaptoethanol, 8% (v/v) glycerol and 0.025% (w/v) bromophenol blue (SDS sample buffer). Proteins were separated onto a 12% SDS-polyacrylamide gels, transferred onto a nitrocellulose membrane (Micron Separations Inc.), and probed with anti-hFen1 rabbit purified antibody followed by horse anti-rabbit IgG-HRP and ECL.
Immunoprecipitation and antibodies
Immunoprecipitations from nuclear HeLa were performed as described (Koundrioukoff et al., 2000) with anti-Cyclin A rabbit (Santa Cruz, H-432), anti-hFen1 rabbit purified antibody and anti-c-myc antibody (9E10). The mouse IgG1 (MOPC-21) from Sigma and rabbit IgG (VECTOR laboratories) antibodies were used as negative controls. Proteins were detected on the nitrocellulose membrane with anti-Cyclin A rabbit or anti-hFen1 rabbit or anti-Cdk2 rabbit (Santa Cruz, H-298) or anti-PCNA mouse (Santa Cruz, PC10) or anti-Cdk1 mouse (Transduction Laboratories, C12729). A phosphorylgroup-specific antibody (Poly-Z-PS1, Zymed Laboratories) was used to detect protein phosphorylated on serine.
In vitro kinase assays
In vitro phosphorylation assays were performed with 100 ng of purified Cdk-Cyclin complexes into a final volume of 18 ml containing 40 mm HEPES-NaOH (pH 7.5), 8 mm MgCl 2 , 33.3 mm ATP, 10 mCi of [g-32 P]ATP (3000 Ci/mmol; Amersham Pharmacia) and the substrates (histone H1, hFen1) to be tested. After 45 min at 301C, the reactions were stopped by adding SDS sample buffer and loaded on a 12% SDSpolyacrylamide gel, electrophoresed for 90 min at 120 V, dried and autoradiographed.
Immunofluorescence
HeLa cells were transfected with CMV-myc-Fen1 by the CaCl 2 method, incubated for 24 h, blocked for 24 h with 4 mm hydroxyurea and released during 3 h. First, nonionic detergent Triton X-100 was used to remove soluble proteins. Then, cells were fixed in methanol at À201C for 10 min and blocked in 5% BSA, 0.1% Tween in PBS (blocking buffer) for 10 min. Subsequently, the cells were incubated with the A-14 polyclonal anti-myc and PC10 anti-PCNA antibodies in blocking solution. Primary antibodies were visualized by Cy.3-conjugated goat anti-rabbit and FITC-conjugated goat anti-mouse antibodies as described (Dahm and Hu¨bscher, 2002) . The coverslips were observed using an epifluorescence microscope (Olympus BX51) and a microscope digital camera system (Olympus DP50).
Cell cycle analysis
In the unsynchronized state, the 293 cells expressing myctagged Fen1 were trypsinized 48 h post-transfection. For synchronization, 293 cells were blocked in S phase 24 h after CaCl 2 transfection. The hydroxyurea block (4 mm) was during 24 h followed by a kinetic release of 105 or 210 min. After trypsinization, the cells were fixed in 70% ethanol, permeabilized in PBS containing 0.2% (v/v) Triton and 100 mg/ml 
